Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07079969 · ClinicalTrials.gov registry record · NA
Effects of Photobiomodulation on Inflammation and Chronic Pain in Knee Osteoarthritis (EPIC-KO)
A NA study, sponsored by University of Florida.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07079969 is a NA study that has not yet begun recruiting, run by University of Florida. The registered enrollment target is 30 participants.
The verdict
NCT07079969, a NA study, has not yet begun recruiting, sponsored by University of Florida.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study aims to determine analgesic and anti-inflammatory effects of dual-wavelength PBM in people with symptomatic knee OA.
Interventions
- DEVICE Photobiomodulation therapy (PBM) device
- DEVICE Sham PBM device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07079969
The ClinicalTrials.gov registry entry for NCT07079969 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Photobiomodulation therapy (PBM) device is the first listed.
NCT07079969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07079969 about?
NCT07079969 is a clinical study titled "Effects of Photobiomodulation on Inflammation and Chronic Pain in Knee Osteoarthritis (EPIC-KO)". This study aims to determine analgesic and anti-inflammatory effects of dual-wavelength PBM in people with symptomatic knee OA.
What is the current status of trial NCT07079969?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-07. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07079969?
The interventions under investigation include: Photobiomodulation therapy (PBM) device (DEVICE), Sham PBM device (DEVICE).
Who is sponsoring clinical trial NCT07079969?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.